(Press-News.org) Researchers have uncovered mutations in the phosphatase Wip1 that enable cancer cells to foil the tumor suppressor p53, according to a study in The Journal of Cell Biology. The results could provide a new target for the treatment of certain cancers.
Like a battlefield surgeon who has to decide which casualties can be saved, p53 performs triage on cells with injured DNA. If the damage is serious, p53 spurs the cells to die or stop proliferating. But after milder hits, p53 activates a DNA damage response (DDR) mechanism, which instigates repairs, and temporarily prevent cells from advancing any farther in the cell cycle. Once cells have mended their DNA, the phosphatase Wip1 enables them to re-enter the cell cycle by shutting down p53 and DDR proteins. Because p53 and the DDR stymie cancer cells, it's no surprise that the rogue cells find ways to circumvent this protection. More than half of all cancers accrue mutations in the p53 gene, for example. Now, researchers from the Czech Republic and the Netherlands tested whether some cells instead carry mutations in the PPM1D gene, which encodes Wip1, to shut down p53.
The team analyzed human tumor cell lines that harbor functional p53. Two of the lines displayed mutations in exon 6 of the PPM1D gene that resulted in a shortened version of Wip1. The truncated Wip1 was more stable than the full-length version of the protein, allowing cells to switch off p53 and continue the cell cycle in the presence of DNA damage. Depleting the truncated Wip1, however, halted the cell cycle until the DNA was repaired.
The researchers then looked for PPM1D mutations in 1,000 patients who had colorectal or breast and ovarian cancer. Four of the patients carried mutations, whereas none of the 450 cancer-free individuals did. All of these DNA alterations fell in exon 6 and caused production of shortened Wip1. To the researchers' surprise, the mutations occurred in the cancer patients' non-tumor cells as well. That suggests that the patients were born with PPM1D mutations, which set them up for cancer later in life but apparently caused no other illnesses.
"We've identified a new mechanism that could lead to inactivation of p53 in cells and inactivation of the DNA damage response," says senior author Libor Macurek. The team suspects that PPM1D mutations could turn up in a variety of tumors. If so, targeting the short but overactive form of Wip1 could provide a new way to treat these cancers.
INFORMATION:
Kleiblova, P., et al. 2013. J. Cell Biol. doi:10.1083/jcb.201210031
About The Journal of Cell Biology
The Journal of Cell Biology (JCB) is published by The Rockefeller University Press. All editorial decisions on manuscripts submitted are made by active scientists in conjunction with our in-house scientific editors. JCB content is posted to PubMed Central, where it is available to the public for free six months after publication. Authors retain copyright of their published works, and third parties may reuse the content for non-commercial purposes under a creative commons license. For more information, please visit http://www.jcb.org
Wip1 could be new target for cancer treatment
2013-05-06
ELSE PRESS RELEASES FROM THIS DATE:
New Canadian guidelines for treating fibromyalgia
2013-05-06
Physicians from the McGill University Health Centre (MUHC) and the University of Calgary have published a review article in the CMAJ (Canadian Medical Association Journal) to help family doctors diagnose and treat fibromyalgia. The article represents the first time researchers have published Canadian guidelines to help manage the condition.
Fibromyalgia is a chronic condition that affects the central nervous system causing pain throughout the body. It is often accompanied by fatigue, depression and sleep problems. It affects mostly women and their multiple symptoms ...
Ubiquitous engineered nanomaterials cause lung inflammation, study finds
2013-05-06
(SACRAMENTO, Calif.) -- A consortium of scientists from across the country has found that breathing ultrafine particles from a large family of materials that increasingly are found in a host of household and commercial products, from sunscreens to the ink in copy machines to super-strong but lightweight sporting equipment, can cause lung inflammation and damage.
The research on two of the most common types of engineered nanomaterials is published online today in Environmental Health Perspectives, the journal of the National Institute of Environmental Health Sciences (NIEHS). ...
LCSB discovers endogenous antibiotic in the brain
2013-05-06
Luxembourg, 6 May 2013 – Scientists from the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg have discovered that immune cells in the brain can produce a substance that prevents bacterial growth: namely itaconic acid. Until now, biologists had assumed that only certain fungi produced itaconic acid. A team working with Dr. Karsten Hiller, head of the Metabolomics Group at LCSB, and Dr. Alessandro Michelucci has now shown that even so-called microglial cells in mammals are also capable of producing this acid. "This is a ground breaking result," ...
Schools may help close gap to mental health services for adolescents with mental disorders
2013-05-06
Washington D.C., May 6, 2013 – A study published in the May 2013 issue of the Journal of the American Academy of Child and Adolescent Psychiatry found that mental health resources provided by schools are significantly associated with whether adolescents with mental disorders receive needed mental health services. In particular, adolescents with disorders attending schools that engage in early identification of emotional problems, are significantly more likely to receive mental health services.
Using data from the National Comorbidity Survey Replication Adolescent Supplement ...
Reversal of the black widow myth
2013-05-06
VIDEO:
Reverse cannibalism: Some male spiders prefer to eat old females rather than mate with them.
Click here for more information.
The Black Widow spider gets its name from the popular belief that female spiders eat their male suitors after mating. However, a new study has shown that the tendency to consume a potential mate is also true of some types of male spider. The study by Lenka Sentenska and Stano Pekar from Masaryk University in the Czech Republic finds that male ...
Possible treatment for serious blood cancer
2013-05-06
A single antibody could be the key to treating multiple myeloma, or cancer of the blood, currently without cure or long-term treatment.
"We tested the antibody in various ways, including on tumour cells from myeloma patients that have been transplanted into mice. The tests showed that the antibody is able to destroy myeloma cells", explains Markus Hansson, a researcher at Lund University in Sweden.
Using a 'biological library' of thousands of antibodies from the company BioInvent in Lund, the team singled out antibody BI-505, shown to have a powerful effect on the ...
Researchers reveal new more precise method of performing electroconvulsive therapy
2013-05-06
Philadelphia, PA, May 6, 2013 - Electroconvulsive therapy (ECT) is the most effective acute treatment for severe major depression. However, even with newer forms of ECT, there remains a significant risk of adverse cognitive effects, particularly memory problems.
Current theories hold that the regions that need to be stimulated to treat the depression (the cortex) are different and separate from the regions that result in memory problems (the hippocampus and temporal lobes). Theoretically, a more precise form of ECT could have all of the efficacy and few or none of the ...
Columbia engineers manipulate a buckyball by inserting a single water molecule
2013-05-06
New York, NY—May 3, 2013—Columbia Engineering researchers have developed a technique to isolate a single water molecule inside a buckyball, or C60, and to drive motion of the so-called "big" nonpolar ball through the encapsulated "small" polar H2O molecule, a controlling transport mechanism in a nanochannel under an external electric field. They expect this method will lead to an array of new applications, including effective ways to control drug delivery and to assemble C60-based functional 3D structures at the nanoscale level, as well as expanding our understanding of ...
The nocebo effect: Media reports may trigger symptoms of a disease
2013-05-06
Media reports about substances that are supposedly hazardous to health may cause suggestible people to develop symptoms of a disease even though there is no objective reason for doing so. This is the conclusion of a study of the phenomenon known as electromagnetic hypersensitivity. Those affected report experiencing certain symptoms on exposure to electromagnetic waves, such as those emitted by cell phones, and these take the form of physical reactions. With the help of magnetic resonance imaging, it has been demonstrated that the regions of the brain responsible for pain ...
Do-it-yourself invisibility with 3-D printing
2013-05-06
DURHAM, N.C. – Seven years ago, Duke University engineers demonstrated the first working invisibility cloak in complex laboratory experiments. Now it appears creating a simple cloak has become a lot simpler.
"I would argue that essentially anyone who can spend a couple thousand dollars on a non-industry grade 3-D printer can literally make a plastic cloak overnight," said Yaroslav Urzhumov, assistant research professor in electrical and computer engineering at Duke's Pratt School of Engineering.
Three-dimensional printing, technically known as stereolithographic fabrication, ...